Platify 50mg Tablet

Platify 50mg tablet is an anticoagulant medication in the thrombopoietin (TPO) receptor agonist class, containing eltrombopag as the active ingredient. It is used to treat low platelet counts resulting from primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells essential for clotting and maintaining blood vessel wall integrity. Low platelet levels can lead to severe bleeding and bruising. The tablet is also indicated in adults for treating low blood counts caused by severe aplastic anaemia, a serious condition where bone marrow fails to produce adequate new blood cells.

This drug must not be used in individuals with known hypersensitivity or allergic reactions to eltrombopag or its components. Allergic reactions range from mild to severe and may present as rash, itching, swelling, dizziness, or difficulty breathing. Platify 50mg tablet is contraindicated in patients with severe liver impairment or active liver disease. The drug can cause hepatotoxicity, evidenced by elevated liver enzymes and bilirubin levels. Use in individuals with severe liver disease may further deteriorate liver function; caution is advised.

Your doctor will recommend screening for cataracts. Regular eye testing should be arranged if you do not undergo routine ophthalmological examinations. You may also be assessed for bleeding in or around the retina, the light-sensitive cell layer at the back of the eye. Upon discontinuing this tablet, your blood platelet count is likely to decline within several days. Platelet count will be monitored, and your doctor will discuss appropriate precautions. Markedly elevated blood platelet counts may increase blood clotting risk. However, blood clots can form with normal or even low platelet counts. Your doctor will adjust your dose to ensure platelet count does not become excessively high.

Do not take this tablet with dairy products or beverages, as calcium impairs medicine absorption. Use effective contraception during treatment; inform your doctor if you become pregnant. Platify 50mg tablet is not advised for children under one year with ITP. It is not recommended for patients under 18 years with low platelet counts from hepatitis C or severe aplastic anaemia.

Inform your doctor of all medicines you are taking, have recently taken, or intend to take, including over-the-counter medicines and vitamins.

Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection. Severe aplastic anemia.

Platify 50mg tablet stimulates megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.

It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take platify 50mg tablet as prescribed by your doctor. Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Nausea Diarrhea, abdominal pain Common cold Cough Respiratory tract infection Back pain High temperature, cough Loss of appetite Hair loss Swelling in feet or hands Headache, dizziness Mouth and throat pain Joint pain

Ensure that in the 2 hours after or 4 hours before you take this medication, you don’t consume dairy foods (such as cheese or butter), milk or milkshakes, antacids, and supplements containing iron, aluminum, magnesium, calcium, selenium, zinc, or calcium. If you forget to take platify 50mg tablet, take your next dose at the usual time. Do not take more than one dose of this drug daily. Don’t stop taking this tablet without talking to your doctor. If your doctor advises you to stop treatment, your platelet count will be checked each week for four weeks. If you have any doubts regarding the use of this medicine, ask your doctor.